There are many health risk factors associated with aging in women that can be improved or reduced through hormone treatment. These include:
Longevity – Comprehensive meta-analyses of randomized controlled trials report a significant reduction in all-cause mortality in women who initiate hormone therapy when aged younger than 60 years.
Cardiovascular Disease – There is a lower overall risk of cardiovascular disease in women who initiate hormone therapy early or within fewer than 10 years after the onset of menopause.
Dementia and Cognitive Decline – Early treatment and prevention is key! Prompt intervention with short-term hormone therapy may lower the risk of Alzheimer’s Disease and some research shows promising reductions in cognitive decline using bioidentical hormones.
Diabetes – A broad analysis of published studies have found that combined hormone therapy reduced type 2 diabetes incidence by almost 40%, with also lowering fasting glucose, and improving insulin resistance.
Bone Loss – Standard doses of hormone therapy in postmenopausal women have been shown to prevent bone loss and reduce osteoporotic fractures.